Literature DB >> 16238595

Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity.

P Kõll-Klais1, R Mändar, E Leibur, H Marcotte, L Hammarström, M Mikelsaar.   

Abstract

BACKGROUND/AIMS: Lactobacilli are known to play an important role in the maintenance of health by stimulating natural immunity and contributing to the balance of microflora. However, their role in chronic periodontitis is unclear. We aimed to identify oral lactobacilli in chronic periodontitis and periodontally healthy subjects, and to determine their antimicrobial activity against putative oral pathogens.
METHODS: A total of 238 Lactobacillus isolates from the saliva and subgingival sites of 20 chronic periodontitis and 15 healthy subjects were collected. In all, 115 strains were identified using rapid amplified ribosomal DNA restriction analysis. Antimicrobial activity against Streptococcus mutans, Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia was assessed.
RESULTS: Lactobacilli belonging to 10 species were identified. The most prevalent strains in healthy persons were Lactobacillus gasseri and Lactobacillus fermentum and in chronic periodontitis patients, Lactobacillus plantarum. Obligately homofermentatives, particularly L. gasseri, were less prevalent in chronic periodontitis patients compared with healthy subjects (8% vs. 64% for L. gasseri, P < 0.01). Sixty-nine percent of tested lactobacilli inhibited S. mutans, 88% A. actinomycetemcomitans, 82% P. gingivalis and 65% P. intermedia. The strongest antimicrobial activity was associated with Lactobacillus paracasei, L. plantarum, Lactobacillus rhamnosus, and Lactobacillus salivarius. The strains from periodontally healthy patients showed a lower antimicrobial activity against S. mutans than the strains from chronic periodontitis patients.
CONCLUSION: The composition of oral lactoflora in chronic periodontitis and healthy subjects differs, with a higher prevalence of homofermentative lactobacilli, particularly L. gasseri, in the latter group. Both homo- and heterofermentative oral lactobacilli suppress the growth of periodontal pathogens, but the antimicrobial properties are strain, species and origin specific.

Entities:  

Mesh:

Year:  2005        PMID: 16238595     DOI: 10.1111/j.1399-302X.2005.00239.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  66 in total

1.  Evaluation of the efficacy of probiotics in plaque reduction and gingival health maintenance among school children - A Randomized Control Trial.

Authors:  R Muthu Karuppaiah; S Shankar; S Krishna Raj; K Ramesh; R Prakash; M Kruthika
Journal:  J Int Oral Health       Date:  2013-10-26

2.  Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on secretion of IL1B, IL6, and IL8 by gingival epithelial cells.

Authors:  Jun-jun Zhao; Xi-ping Feng; Xiu-li Zhang; Ke-yi Le
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Probiotic strains of Lactobacillus brevis and Lactobacillus plantarum as adjunct to non-surgical periodontal therapy: 3-month results of a randomized controlled clinical trial.

Authors:  P Pudgar; K Povšič; K Čuk; K Seme; M Petelin; R Gašperšič
Journal:  Clin Oral Investig       Date:  2020-07-14       Impact factor: 3.573

4.  Gingival epithelial barrier: regulation by beneficial and harmful microbes.

Authors:  Naoki Takahashi; Benso Sulijaya; Miki Yamada-Hara; Takahiro Tsuzuno; Koichi Tabeta; Kazuhisa Yamazaki
Journal:  Tissue Barriers       Date:  2019-08-07

5.  Competitive selection of lactic acid bacteria that persist in the human oral cavity.

Authors:  Johannes Snel; Maria L Marco; Fedde Kingma; Wouter M Noordman; Jan Rademaker; Michiel Kleerebezem
Journal:  Appl Environ Microbiol       Date:  2011-09-30       Impact factor: 4.792

6.  Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Authors:  T Maekawa; G Hajishengallis
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

7.  Probiotics and oral health.

Authors:  Anna Haukioja
Journal:  Eur J Dent       Date:  2010-07

8.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

9.  Lactobacillus paracasei SD1, a novel probiotic, reduces mutans streptococci in human volunteers: a randomized placebo-controlled trial.

Authors:  Rawee Teanpaisan; Supatcharin Piwat
Journal:  Clin Oral Investig       Date:  2013-07-28       Impact factor: 3.573

10.  Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study.

Authors:  Bengt Klarin; Göran Molin; Bengt Jeppsson; Anders Larsson
Journal:  Crit Care       Date:  2008-11-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.